3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT
申请人:Usui Shuichi
公开号:US20120022263A1
公开(公告)日:2012-01-26
The present invention herein provides a 3-aminooxalylaminobenzamide derivative which is used as an insecticide or miticide.
The 3-aminooxalylaminobenzamide derivative is one represented by the following general formula [1]:
(R
1
and R
2
each represent, for instance, a C
1
to C
3
alkoxy group or a C
1
to C
3
haloalkoxy group; R
3
and R
4
each represent, for instance, a C
1
to C
8
alkyl group or a C
1
to C
8
haloalkyl group; R
5
represents, for instance, a C
1
to C
5
haloalkyl group; R
6
and R
7
each represent, for instance, a hydrogen atom or a C
1
to C
5
alkyl group; Y represents, for instance, a hydrogen atom or a halogen atom; Z represents, for instance, a hydrogen atom; n is an integer ranging from 0 to 4 and m is an integer ranging from 0 to 2).
ALKOXYCARBONATE ESTER PRODRUGS FOR USE AS ANTIMALARIAL AGENTS
申请人:OREGON HEALTH & SCIENCE UNIVERSITY
公开号:US20200369616A1
公开(公告)日:2020-11-26
Provided are compounds of Formula (I):
wherein: X is selected from the group of F and Cl; Y is selected from the group of —CH
2
—, —CH
2
—CH
2
—, and —CH(CH
3
)—; R
1
is selected from cycloalkyl, heterocyclyl, aromatic, heteroaromatic, and linear and branched alkyl, alkenyl, and alkynyl chains.
The present invention relates to a method for preparing a furofuran lignan compound, comprising a step of selecting and alkylating an epoxy alcohol compound and an optical isomer thereof. (+)-furofuran lignan and (−)-furofuran lignan, as well as an optical isomer thereof, can be selectively prepared by means of the method.
METHODS FOR CONVERTING CBD TO TETRAHYDROCANNABINOLS
申请人:Cannacraft, Inc.
公开号:US20210221783A1
公开(公告)日:2021-07-22
This disclosure provides a method for converting CBD to a tetrahydrocannabinol featuring the use of cheap and non-toxic aluminum isopropoxide as a catalyst. The method comprises (a) providing a reaction mixture comprising a catalyst in an organic solvent, wherein the catalyst comprises aluminum isopropoxide; (b) adding a reagent comprising CBD to the reaction mixture; (c) mixing the reaction mixture and allowing a reaction for converting CBD to a tetrahydrocannabinol to occur for a predetermine period of time; (d) removing the catalyst by filtration upon the completion of the reaction; (e) removing the organic solvent; and (f) eluting the tetrahydrocannabinol from the organic phase.
USE OF CYP EXPRESSION TO DIRECT THERAPEUTIC INTERVENTION IN CANCER
申请人:REGENTS OF THE UNIVERSITY OF MINNESOTA
公开号:US20180177749A1
公开(公告)日:2018-06-28
Certain embodiments of the invention provide a method for identifying a cancer cell that is sensitive to a biguanide compound or other CYP epoxygenase inhibitor, comprising detecting increased expression of at least one cytochrome P450 (CYP) and/or decreased expression of soluble epoxide hydrolase (EPHX2) in the cancer cell, wherein increased CYP expression and/or decreased expression of EPHX2 in the cancer cell correlates with increased sensitivity of the cancer cell to the biguanide compound or other CYP epoxygenase inhibitor.